Comparison 5. Agent with longer half‐life versus similar agent with shorter half‐life.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Treatment failure | 2 | 484 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.61 [0.40, 0.92] |
2 Severe complication | 1 | 355 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.27 [0.02, 2.89] |
3 Wound infection | 2 | 484 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.70 [0.13, 3.68] |
4 Allergic reaction | 1 | 377 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.78 [0.22, 2.72] |
5 Diarrhea | 1 | 129 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.43 [0.42, 4.84] |
6 Length of stay | 1 | 129 | Mean Difference (IV, Fixed, 95% CI) | ‐0.60 [‐1.45, 0.25] |